newsfilter
← Latest News
PR Newswire·

MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing

NEW YORK, May 26, 2021 /PRNewswire/ -- MindMed (NASDAQ:MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data on LSD to help personalize dosing. The study results fro